Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Histone Deacetylases
100%
Histone Deacetylase Inhibitor (HDACi)
80%
Molecular Mechanism
20%
Combination Therapy
20%
Expression Pattern
20%
Clinical Setting
20%
Cancer Cells
20%
Therapeutic Strategies
20%
Over 80
20%
Isoenzymes
20%
Mode of Action
20%
Angiogenesis
20%
Effective Therapy
20%
Proliferation Apoptosis
20%
Metastatic Tumor
20%
Pancreatic Cancer
20%
5-year Survival
20%
Novel Therapeutic Targets
20%
Median Survival
20%
Rational Therapeutics
20%
Locally Advanced Cancer
20%
Clinical Relapse
20%
Advanced or Metastatic
20%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Histone Deacetylase
100%
Histone Deacetylase Inhibitor
50%
Combination Therapy
16%
Programmed Cell Death
16%
Metastatic Carcinoma
16%
Survival Rate
16%
Angiogenesis
16%
Cancer Cell
16%
Translating (Language)
16%
Pancreas Cancer
16%
Pancreatic Ductal Adenocarcinoma
16%
Isoenzyme
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
100%
Histone Deacetylase
100%
Histone Deacetylase Inhibitor
50%
Pancreas Cancer
16%
Malignant Neoplasm
16%
Metastasis
16%
Survival Rate
16%
Combination Therapy
16%
Isoenzyme
16%
Diseases
16%
Biochemistry, Genetics and Molecular Biology
Histone Deacetylase
100%
Isoenzyme
20%
Cancer Cell
20%
Survival Rate
20%
Translating (Language)
20%
Angiogenesis
20%
Histone Deacetylases Inhibitor
20%
Programmed Cell Death
20%